Lupin Digital Health, American College of Cardiology introduce Digital Therapeutics Certificate for Cardiologists in India
Mumbai: Lupin Digital Health, an evidence-based cardiology Digital Therapeutics (DTx) platform and the American College of Cardiology (ACC) have announced the introduction of the world's first-ever Digital Therapeutics Certificate for Cardiologists.
This unveiling took place during the Platinum Jubilee celebration event of the Cardiology Society of India (CSI) in Kolkata. Dr. Edward Fry, the Past President of ACC, attended the event, emphasizing the global significance of this collaboration in advancing cardiovascular patient care. In a bid to encourage the integration of cutting-edge digital solutions in Cardiology, ACC will grant 'Digital Pioneer' certificates to cardiologists who adopt Remote Cardiac Rehab and Digital Heart Failure clinic solutions.
Expressing enthusiasm about this initiative, Rajeev Sibal, President - India Region Formulations, Lupin stated, "Lupin is proud to support cardiologists with our patient-centric solutions. As a pioneer in the DTx space, we are delighted to play a pivotal role in bringing this important ACC certificate to cardiologists and setting new standards in digital therapeutics."
Sidharth Srinivasan, CEO, Lupin Digital Health added, "The collaboration with the American College of Cardiology marks a transformative milestone in remote cardiac rehabilitation. A growing number of doctors and cardiac institutes are acknowledging Remote Cardiac Rehab as a foundational pillar in making cardiac care more accessible. We are sure that this initiative will further encourage the healthcare fraternity to better understand and utilize technology-led Cardiac Rehab."
Ami Bhatt, MD, ACC Chief Innovation Officer, highlighted the broader impact, "The ACC is proud to recognize cardiologists who are pioneering digital therapeutics adaptation in India through Lupin Digital Health’s Lyfe platform. This recognition underscores our commitment to advancing digital solutions that improve patient outcomes globally."
"Lyfe, developed by Lupin Digital Health, is India's first clinically proven remote cardiac rehabilitation program. Addressing the underutilization of cardiac rehabilitation, Lyfe is trusted by over 450 cardiologists with patients across 250 towns and cities in India. The program has demonstrated its effectiveness in enhancing heart health and improving the quality of life for cardiovascular patients. This collaboration is a significant step forward in global healthcare, aligning with the mission of both Lupin Digital Health and the American College of Cardiology to revolutionize cardiovascular patient care through innovative digital solutions," the Company stated.
Read also: Lupin bags tentative USFDA approval for Rivaroxaban Tablets
